Corbion announces strong first quarter 2025 results, well on track to deliver full-year outlook

23.04.25 07:00 Uhr

Werte in diesem Artikel
Aktien

18,45 EUR 1,26 EUR 7,33%

DATE 23 April 2025
  Corbion Q1 2025 Interim Management Statement
   
Wer­bung


Corbion announces strong first quarter 2025 result, well on track to deliver full-year outlook

Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through application of science, today publishes its results for Q1 2025 ending 31 March.

Key highlights Q1 2025:
    Organic sales growth:+7.9%
 ?    Volume/mix:+8.4%
 ?    Price:-0.5%
    Sales: € 329.7 million
    Adjusted EBITDA: € 54.4 million, an organic increase of +53.9%
    Operating profit: € 34.0 million, an organic increase of +186%
    FY 2025 outlook affirmed
Wer­bung


€ millionQ1 2025 Q1 20241  Total growth Organic growth 
Sales329.7 300.4  +9.8% +7.9% 
Adjusted EBITDA54.4 34.5  +57.7% +53.9% 
Adjusted EBITDA margin (%)16.5% 11.5%      
Operating Profit34.0 11.6  +193.1% 186.2% 


Commenting on today’s results, Olivier Rigaud, CEO, stated: "Corbion had an excellent start to 2025. I am pleased to report on this strong quarter with positive volume/mix and organic Adjusted EBITDA growth, as well as positive free cash flow. Corbion provides essential, natural solutions to meet customers’ preservation and nutrition needs, and the Q1 results highlight the resilience of our businesses.

In Functional Ingredients & Solutions, we delivered volume/mix growth in all three businesses (Food, Biochemicals, and Lactic acid to the PLA JV), and we are seeing the results of our efficiency and cost-management measures translating into improved margins to greater than 12%.

Wer­bung

In Health & Nutrition, we delivered volume/mix growth across all three businesses (Nutrition, Biomedical polymers, and Pharma), with Adjusted EBITDA margins exceeding 30% for the business unit overall.

As we navigate the macro-economic and geopolitical uncertainty, we continue to execute on our strategy and remain on track to deliver our 2025 guidance on all forecasted metrics, including volume/mix, Adjusted EBITDA, and free cash flow.”

________________________
1 Q1 2024 values are presented as continued operations in all tables

 

Attachment


Ausgewählte Hebelprodukte auf Corbion NV

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Corbion NV

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Corbion NV

Wer­bung